The chemical synthesis of ketoisophorone, a valuable building block of vitamins and pharmaceuticals, suffers from several drawbacks in terms of reaction conditions and selectivity. Herein, the first biocatalytic one‐pot double oxidation of the readily available α‐isophorone to ketoisophorone is described. Variants of the self‐sufficient P450cam‐RhFRed with improved activity have been identified to perform the first step of the designed cascade (regio‐ and enantioselective allylic oxidation of α‐isophorone to 4‐hydroxy‐α‐isophorone). For the second step, the screening of a broad panel of alcohol dehydrogenases (ADHs) led to the identification of Cm‐ADH10 from Candida magnoliae. The crystal structure of Cm‐ADH10 was solved and docking experiments confirmed the preferred position and geometry of the substrate for catalysis. The synthesis of ketoisophorone was demonstrated both as a one‐pot two‐step process and as a cascade process employing designer cells co‐expressing the two biocatalysts, with a productivity of up to 1.4 g L−1 d−1.